These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36420768)

  • 41. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decision-Making Preferences and Deprescribing: Perspectives of Older Adults and Companions About Their Medicines.
    Weir K; Nickel B; Naganathan V; Bonner C; McCaffery K; Carter SM; McLachlan A; Jansen J
    J Gerontol B Psychol Sci Soc Sci; 2018 Sep; 73(7):e98-e107. PubMed ID: 29190369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Planning and optimising CHAT&PLAN: A conversation-based intervention to promote person-centred care for older people living with multimorbidity.
    Corbett TK; Cummings A; Lee K; Calman L; Fenerty V; Farrington N; Lewis L; Young A; Boddington H; Wiseman T; Richardson A; Foster C; Bridges J
    PLoS One; 2020; 15(10):e0240516. PubMed ID: 33064764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
    van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
    Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attitudes of Older Adult Patients and Caregivers Towards Deprescribing of Medications in Ethiopia.
    Gadisa DA; Gebremariam ET; Yimer G; Deresa Urgesa E
    Clin Interv Aging; 2023; 18():1129-1143. PubMed ID: 37522072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trial.
    Sheehan OC; Gleason KS; Bayliss EA; Green AR; Drace ML; Norton J; Reeve E; Shetterly SM; Weffald LA; Sawyer JK; Maciejewski ML; Kraus C; Maiyani M; Wolff J; Boyd CM
    J Am Geriatr Soc; 2023 Mar; 71(3):774-784. PubMed ID: 36508725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
    Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
    Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers and facilitators to deprescribing before surgery: A qualitative study of providers and older adults.
    Lee JW; Jeong S; Han HR; Boyd CM; Perrin N; Simmons SF; Green AR; Taylor JL; Boucher HR; Szanton SL
    Geriatr Nurs; 2023; 53():135-140. PubMed ID: 37540907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction.
    Navid P; Nguyen L; Jaber D; Zarzuela K; Musse M; Lu Wang M; Requijo T; Kozlov E; Masterson Creber RM; Hilmer SN; Lachs M; Goyal P
    J Am Geriatr Soc; 2021 Jul; 69(7):1948-1955. PubMed ID: 33978239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
    Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
    J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applying the AFRAID and FRIGHT Clocks to Novel Preclinical Mouse Models of Polypharmacy.
    Mach J; Kane AE; Howlett SE; Sinclair DA; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2022 Jul; 77(7):1304-1312. PubMed ID: 35313348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Study on the Perceptions of Korean Older Adult Patients and Caregivers about Polypharmacy and Deprescribing.
    Lee HG; Kwon S; Jang BH; Jeon JP; Lee YS; Jung WS; Moon SK; Cho KH
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Appropriate deprescribing in older people: a challenging necessityCommentary to accompany themed collection on deprescribing.
    van der Velde N; Minhas JS
    Age Ageing; 2021 Sep; 50(5):1516-1519. PubMed ID: 34260681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice.
    Junius-Walker U; Viniol A; Michiels-Corsten M; Gerlach N; Donner-Banzhoff N; Schleef T
    Drugs Aging; 2021 Aug; 38(8):725-733. PubMed ID: 34251594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.